Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy

Clinical trial NCT00191841 · COMPLETED

Trial details

NCT number: NCT00191841
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2002-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.